{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:38:02Z","timestamp":1770507482937,"version":"3.49.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.clinthera.2011.01.009","type":"journal-article","created":{"date-parts":[[2011,2,24]],"date-time":"2011-02-24T09:06:24Z","timestamp":1298538384000},"page":"2316-2336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Effectiveness of Systemic Antifungal Prophylaxis in Patients With Neutropenia After Chemotherapy: A Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.1016","volume":"32","author":[{"given":"Panayiotis D.","family":"Ziakas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene S.","family":"Kourbeti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Voulgarelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleftherios","family":"Mylonakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2011.01.009_bib1","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1002\/cncr.24507","article-title":"Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001\u20132007): Stable incidence but changing epidemiology of a still frequently lethal infection","volume":"115","author":"Sipsas","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.clinthera.2011.01.009_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/318483","article-title":"Aspergillosis case-fatality rate: Systematic review of the literature","volume":"32","author":"Lin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2011.01.009_bib3","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1200\/JCO.2007.12.3851","article-title":"Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: Systematic review and meta-analysis","volume":"25","author":"Robenshtok","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinthera.2011.01.009_bib4","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1002\/cncr.10610","article-title":"Antifungal prophylaxis for severely neutropenic chemotherapy recipients: A meta analysis of randomized-controlled clinical trials","volume":"94","author":"Bow","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.clinthera.2011.01.009_bib5","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1136\/bmj.314.7089.1238","article-title":"Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia","volume":"314","author":"G\u00f8tzsche","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2011.01.009_bib6","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1136\/bmj.38446.498542.8F","article-title":"Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: Analytical survey","volume":"330","author":"Haynes","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2011.01.009_bib7","first-page":"451","article-title":"Comparison of top-performing search strategies for detecting clinically sound treatment studies and systematic reviews in MEDLINE and EMBASE","volume":"94","author":"Wong","year":"2006","journal-title":"J Med Libr Assoc"},{"key":"10.1016\/j.clinthera.2011.01.009_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2011.01.009_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.clinthera.2011.01.009_bib10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2307\/2531052","article-title":"Estimators of the Mantel-Haenszel variance consistent in both sparse data and large-strata limiting models","volume":"42","author":"Robins","year":"1986","journal-title":"Biometrics"},{"key":"10.1016\/j.clinthera.2011.01.009_bib11","doi-asserted-by":"crossref","first-page":"578","DOI":"10.7326\/0003-4819-147-8-200710160-00182","article-title":"Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascular death","volume":"147","author":"Diamond","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2011.01.009_bib12","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2011.01.009_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/sim.2528","article-title":"Much ado about nothing: A comparison of the performance of meta-analytical methods with rare events","volume":"26","author":"Bradburn","year":"2007","journal-title":"Stat Med"},{"key":"10.1016\/j.clinthera.2011.01.009_bib14","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Stat Med"},{"key":"10.1016\/j.clinthera.2011.01.009_bib15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2011.01.009_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","article-title":"Interaction revisited: The difference between two estimates","volume":"326","author":"Altman","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2011.01.009_bib17","doi-asserted-by":"crossref","first-page":"820","DOI":"10.7326\/0003-4819-127-9-199711010-00008","article-title":"Quantitative synthesis in systematic reviews","volume":"127","author":"Lau","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2011.01.009_bib18","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008)","year":"2008"},{"key":"10.1016\/j.clinthera.2011.01.009_bib19","unstructured":"O'Rourke K. Mixed means and medians: A unified approach to deal with disparate outcome summaries. In: Proceedings of the 4th Symposium on Systematic Reviews: Pushing the Boundaries; July 2\u20134, 2002; Oxford, UK."},{"key":"10.1016\/j.clinthera.2011.01.009_bib20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1439-0507.1983.tb03203.x","article-title":"Prevention of mycosis in granulocytopenic patients with prophylactic ketoconazole treatment","volume":"26","author":"Brincker","year":"1983","journal-title":"Mykosen"},{"key":"10.1016\/j.clinthera.2011.01.009_bib21","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1001\/archinte.1984.00350200054006","article-title":"Infection prophylaxis in acute leukemia","volume":"144","author":"Estey","year":"1984","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2011.01.009_bib22","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1001\/archinte.1987.00370040092016","article-title":"Ketoconazole in the prevention of candidiasis in patients with cancer","volume":"147","author":"Hansen","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2011.01.009_bib23","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0002-9343(87)90949-1","article-title":"Prevention of fungal sepsis in patients with prolonged neutropenia: A randomized, double-blind, placebo-controlled trial of intravenous miconazole","volume":"83","author":"Wingard","year":"1987","journal-title":"Am J Med"},{"issue":"Suppl 3","key":"10.1016\/j.clinthera.2011.01.009_bib24","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.1093\/clinids\/12.Supplement_3.S369","article-title":"Prophylaxis of oropharyngeal candidiasis with fluconazole","volume":"12","author":"Samonis","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.clinthera.2011.01.009_bib25","first-page":"127","article-title":"Does ketoconazole prevent fungal infection in children treated with high dose chemotherapy and bone marrow transplantation?","volume":"7","author":"Benhamou","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clinthera.2011.01.009_bib26","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2011.01.009_bib27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2796.1992.tb00945.x","article-title":"Oral ketoconazole prophylaxis for Candida infections during induction therapy for acute leukaemia in adults: More bacteraemias","volume":"231","author":"Palmblad","year":"1992","journal-title":"J Intern Med"},{"key":"10.1016\/j.clinthera.2011.01.009_bib28","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/infdis\/165.5.891","article-title":"Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients","volume":"165","author":"Perfect","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2011.01.009_bib29","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7326\/0003-4819-118-7-199304010-00003","article-title":"Fluconazole prophylaxis of fungal infections in patients with acute leukemia","volume":"118","author":"Winston","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2011.01.009_bib30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/10428199309067926","article-title":"Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy","volume":"11","author":"Vreugdenhil","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clinthera.2011.01.009_bib31","first-page":"577","article-title":"Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients","volume":"12","author":"Tollemar","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clinthera.2011.01.009_bib32","first-page":"1495","article-title":"Prophylactic use of liposomal amphotericin B (AmBisome) against fungal infections: A randomized trial in bone marrow transplant recipients","volume":"25","author":"Tollemar","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1016\/j.clinthera.2011.01.009_bib33","first-page":"1833","article-title":"Fungal prophylaxis with AmBisome in liver and bone marrow transplant recipients: Results of two randomized double-blind studies","volume":"26","author":"Tollemar","year":"1994","journal-title":"Transplant Proc"},{"key":"10.1016\/j.clinthera.2011.01.009_bib34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jac\/33.2.309","article-title":"The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients","volume":"33","author":"Chandrasekar","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2011.01.009_bib35","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000239184","article-title":"Effect of fluconazole prophylaxis on fever and use of amphotericin in neutropenic cancer patients","volume":"40","author":"Chandrasekar","year":"1994","journal-title":"Chemotherapy"},{"key":"10.1016\/j.clinthera.2011.01.009_bib36","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0002-9343(94)90345-X","article-title":"The prophylactic use of low-dose amphotericin B in bone marrow transplant patients","volume":"97","author":"Riley","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2011.01.009_bib37","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/infdis\/172.4.1035","article-title":"Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias","volume":"172","author":"Schaffner","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2011.01.009_bib38","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","article-title":"Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation\u2014a prospective, randomized, double-blind study","volume":"171","author":"Slavin","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2011.01.009_bib39","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/pgmj.71.835.284","article-title":"Prophylactic use of fluconazole in neutropenic cancer patients","volume":"71","author":"Yama\u00e7","year":"1995","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.clinthera.2011.01.009_bib40","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<291::AID-CNCR13>3.0.CO;2-O","article-title":"Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: Results of a prospective randomized phase III study","volume":"83","author":"Kern","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.clinthera.2011.01.009_bib41","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.bmt.1701543","article-title":"Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: A randomised, double-blind, placebo-controlled study","volume":"23","author":"Kelsey","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clinthera.2011.01.009_bib42","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/515129","article-title":"Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: A randomized, placebo-controlled, double-blind, multicenter trial","volume":"28","author":"Menichetti","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2011.01.009_bib43","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/515128","article-title":"Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: Benefit based on purpose and intensity of cytotoxic therapy","volume":"28","author":"Rotstein","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2011.01.009_bib44","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood.V96.6.2055","article-title":"Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: Long-term follow-up of a randomized, placebo-controlled trial","volume":"96","author":"Marr","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2011.01.009_bib45","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1086\/313654","article-title":"A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients","volume":"30","author":"Nucci","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2011.01.009_bib46","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/jac\/46.6.1001","article-title":"Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients","volume":"46","author":"Laverdi\u00e8re","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2011.01.009_bib47","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s10156-002-0207-5","article-title":"Itraconazole is not effective for the prophylaxis of fungal infections in patients with neutropenia","volume":"9","author":"Kaptan","year":"2003","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.clinthera.2011.01.009_bib48","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/annonc\/mdl128","article-title":"Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: Results from a randomized, single-center trial","volume":"17","author":"Penack","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clinthera.2011.01.009_bib49","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jinf.2007.07.003","article-title":"A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML)","volume":"55","author":"Vehreschild","year":"2007","journal-title":"J Infect"},{"key":"10.1016\/j.clinthera.2011.01.009_bib50","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/jme.2008.024299","article-title":"A comparison of journal instructions regarding institutional review board approval and conflict-of-interest disclosure between 1995 and 2005","volume":"35","author":"Rowan-Legg","year":"2009","journal-title":"J Med Ethics"},{"key":"10.1016\/j.clinthera.2011.01.009_bib51","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","article-title":"2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer","volume":"34","author":"Hughes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2011.01.009_bib52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/146532401753156403","article-title":"Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients","volume":"3","year":"2001","journal-title":"Cytotherapy"},{"key":"10.1016\/j.clinthera.2011.01.009_bib53","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1600-0609.2006.00805.x","article-title":"Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies","volume":"78","author":"Maertens","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clinthera.2011.01.009_bib54","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/cncr.23466","article-title":"The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy","volume":"112","author":"Hachem","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.clinthera.2011.01.009_bib55","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1056\/NEJM199110313251803","article-title":"Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole","volume":"325","author":"Wingard","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2011.01.009_bib56","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1086\/510677","article-title":"Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts","volume":"44","author":"Segal","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2011.01.009_bib57","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/QCO.0b013e32832e074d","article-title":"Prevention and treatment of invasive fungal diseases in neutropenic patients","volume":"22","author":"Almyroudis","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.clinthera.2011.01.009_bib58","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1086\/423274","article-title":"Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole","volume":"39","author":"Imhof","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2011.01.009_bib59","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1056\/NEJM200402263500923","article-title":"Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants","volume":"350","author":"Marty","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2011.01.009_bib60","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/428780","article-title":"Zygomycosis in a tertiary care cancer center in the era of Aspergillus-active antifungal therapy: A case control observational study of 27 recent cases","volume":"191","author":"Kontoyannis","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2011.01.009_bib61","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1086\/430710","article-title":"Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer","volume":"41","author":"Chamilos","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2011.01.009_bib62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.diagmicrobio.2005.01.001","article-title":"Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli","volume":"52","author":"Lionakis","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.clinthera.2011.01.009_bib63","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bbmt.2009.04.007","article-title":"Fatal rhizopus pneumonia in allogeneic stem cell transplant patients despite posaconazole prophylaxis: Two cases and review of the literature","volume":"15","author":"Lekakis","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clinthera.2011.01.009_bib64","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/jac\/33.6.1223","article-title":"The effect of fluconazole as prophylaxis for neutropenic patients on the isolation of Candida spp. from surveillance cultures","volume":"33","author":"Ellis","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2011.01.009_bib65","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/1097-0142(20001001)89:7<1611::AID-CNCR27>3.0.CO;2-B","article-title":"Prophylactic action of oral fluconazole against fungal infection in neutropenic patients","volume":"89","author":"Kanda","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.clinthera.2011.01.009_bib66","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/315193","article-title":"Candidemia in allogeneic blood and marrow transplant recipients: Evolution of risk factors after the adoption of prophylactic fluconazole","volume":"181","author":"Marr","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2011.01.009_bib67","doi-asserted-by":"crossref","first-page":"412","DOI":"10.7326\/0003-4819-135-6-200109180-00010","article-title":"Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy","volume":"135","author":"Boogaerts","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2011.01.009_bib68","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200201243460403","article-title":"Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever [published correction appears in N Engl J Med. 2007;356:760]","volume":"346","author":"Walsh","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2011.01.009_bib69","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2011.01.009_bib70","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1182\/blood-2002-05-1356","article-title":"Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies","volume":"101","author":"Cornely","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2011.01.009_bib71","first-page":"139","article-title":"Nystatin prophylaxis of fungal colonization and infection in granulocytopenic patients: Correlation of colonization and clinical outcome","volume":"8","author":"Buchanan","year":"1985","journal-title":"Clin Invest Med"},{"issue":"4","key":"10.1016\/j.clinthera.2011.01.009_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002033","article-title":"Nystatin prophylaxis and treatment in severely immunodepressed patients","author":"G\u00f8tzsche","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2011.01.009_bib73","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/jac\/31.6.973","article-title":"Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia","volume":"31","author":"Philpott-Howard","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2011.01.009_bib74","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/jac\/27.3.369","article-title":"A randomized study to compare oral fluconazole to amphotericin B in the prevention of fungal infections in patients with acute leukaemia","volume":"27","author":"Rosenberg-Arska","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2011.01.009_bib75","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1185\/030079908X253816","article-title":"Decreasing the incidence and impact of infections in neutropenic patients: Evidence from meta-analyses of randomized controlled trials","volume":"24","author":"Falagas","year":"2008","journal-title":"Curr Med Res Opin"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811000105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811000105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:48:31Z","timestamp":1758962911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291811000105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":75,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0149291811000105"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2011.01.009","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of Systemic Antifungal Prophylaxis in Patients With Neutropenia After Chemotherapy: A Meta-Analysis of Randomized Controlled Trials","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2011.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}